Funding Rounds
Immatics Biotechnologies Series B round
Immatics BiotechnologiesImmatics Biotechnologies is a biopharmaceutical company focused on the discovery and development of immunotherapy of cancer.
Summary
Stage: Series B
Raised Amount: $7.50M
Raised Date: 2005-04-15
